STANDARD BIOTOOLS INC. (LAB)
Standard BioTools Inc. engages in the provision of biotechnology tools and services for clinical research. It sells preparatory and analytical instruments for mass cytometry, polymerase chain reaction, library prep, single cell genomics, and consumables including integrated fluidic circuits (IFCs), assays, and reagents. The company was founded by Stephen D. Quake and Gajus Vincent Worthington on May 19, 1999 and is headquartered in South San Francisco, CA.
Address
2 TOWER PLACE
SOUTH SAN FRANCISCO, CA 94080
Founded
1999
Number of Employees
539
Website
http://www.standardbio.com
Buyback
| Buyback Data | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $ Amount Purchased ($ in 000s) |
- | - | - | - | - | - | - | - | $562 | $10,471 | $40,466 | $17,166 |
| Average Price | - | - | - | - | - | - | - | - | $1.33 | $1.99 | $2.62 | $2.44 |
| # Shares Purchased | - | - | - | - | - | - | - | - | 422,309 | 5,269,188 | 15,448,533 | 7,046,677 |
| Buyback Performance | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | Average |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Return to Date | - | - | - | - | - | - | - | - | 50.4% | 0.6% | -23.6% | -17.9% |
| S&P 500 Return to Date | - | - | - | - | - | - | - | - | 37.3% | 31.3% | 7.4% | 25.3% |
| Excess Total Return | - | - | - | - | - | - | - | - | 13.1% | -30.7% | -31.1% | -43.2% |
| Quartile Rank |
|
|
|
|
|
|
|
|
|
|
|
|
| Percentile Rank | - | - | - | - | - | - | - | - | 80% | 38% | 11% | 29% |
Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.
Insider Transactions
Filters
Keyboard Shortcuts: Show (a) | Close (Esc)
Never miss an email alert when insiders at LAB make a trade.
Creating a free account takes less than one minute